Howard Global Holdings Company is a private global investment company with over $6 billion of diverse interests and capabilities. Established in 1921 as Howard Enterprises, today HGH is considered one of the largest privately owned companies in the world. Across the continents we provide innovative, high quality and price competitive products and services as well as investment opportunities for private investors, partners and stakeholders in the industrial, petrochemicals and services sectors.
Howard Global Holdings knows that private equity is the engine behind the entrepreneurial activity that drives innovation, productivity and ultimately, prosperity in markets around the world. HGH believes the key to success in the private equity arena is a discriminating eye for value in a crowded market, combined with support for one’s holdings while broader investor sentiment surges and ebbs.
At Howard Global Holdings we strive for long-term investments and seek businesses with strong management teams that are capable of delivering sustained growth and continuously strong returns. We continue to support management teams while seeking to be a active investors. These active investment positions are large enough to give HGH a voice in the strategic management of our portfolio companies.
Our reputation has been achieved through a focus on growth sectors where value can be added. Predominantly these sectors are technology, consumer, healthcare, manufacturing, and the pharmaceutical industry sector.
Howard GSA has developed extensive contacts among government and business leaders globally. These contacts allow Howard Global Holdings to gain access to positive synergies among separate partners.
As a major company with global interests, HGH is committed to operating to the very highest ethical & moral standards. This common goal is extended to our company’s ever-growing portfolio of investments.
HGH is pursuing investments in healthcare on three strategic fronts, healthcare provision, technology and Pharmaceuticals. HGH is working to establish quality healthcare offerings worldwide.
However nationally, we seek to support innovative healthcare providers that can address the burgeoning unmet demand for quality patient care, whether in partnership, management or total acquisition.
Despite its high-risk designation, Howard Global Holdings continues to be bullish. We understand high-risk can put off the markets, long-term investing in pharmaceutical stocks and the possibility of patented entry into new areas of treatments create a compelling argument for investors to look into those companies. Evolving diseases and our understanding of this drive forward our need for new cures not just treatments. With researchers and medical officers working years to develop new candidates that, after multiple rounds of rigorous testing, could bring a significant impact into the battle against serious ailments like diabetes, Zika or Parkinson’s disease.
It is no exaggeration to say Internet enabled social media advances and their supporting technologies have changed the way billions connect with one another, share information,
buy goods, and effect political change.
HGH is investing with confidence in social media and technology ventures that make a profound difference in human interaction.
Copyright © 2019 Howard Global Holdings - All Rights Reserved.